dipyridamole has been researched along with Gangrene in 9 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Gangrene: Death and putrefaction of tissue usually due to a loss of blood supply.
| Excerpt | Relevance | Reference |
|---|---|---|
| " centers, 231 male diabetic patients who had either a recent amputation for gangrene (N = 207) or active gangrene (N = 24) were randomly assigned to a group which received aspirin (325 mg t." | 5.05 | V.A. Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: III. Definitions and review of design and baseline characteristics. ( Abraira, C; Anderson, JW; Bingham, SF; Colwell, JA; Kwaan, HC, 1985) |
| "Thirty-five patients with gangrene or pregangrene of the feed associated with palpable peripheral pulses have been treated with the platelet suppressive drugs aspirin and dipyridamole." | 3.66 | Gangrene of the toes with palpable peripheral pulses. ( Chatterjee, DK; Greaney, M; Morris-Jones, W; Preston, FE, 1981) |
| "We report a 1-month-old infant with Kawasaki disease and peripheral gangrene." | 1.33 | Infantile Kawasaki disease and peripheral gangrene. ( Durall, AL; Mullett, CJ; Phillips, JR; Weisse, ME, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (88.89) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Durall, AL | 1 |
| Phillips, JR | 1 |
| Weisse, ME | 1 |
| Mullett, CJ | 1 |
| Heidrich, H | 1 |
| Branson, HE | 1 |
| Endo, Y | 1 |
| Fagin, AR | 1 |
| Schlutz, M | 1 |
| Colwell, JA | 3 |
| Bingham, SF | 3 |
| Abraira, C | 2 |
| Anderson, JW | 2 |
| Kwaan, HC | 2 |
| Chen, WY | 1 |
| Lee, FN | 1 |
| Hsieh, BS | 1 |
| Yen, TS | 1 |
| Chou, JH | 1 |
| Morris-Jones, W | 1 |
| Preston, FE | 1 |
| Greaney, M | 1 |
| Chatterjee, DK | 1 |
| Poldre, P | 1 |
| Pruzanski, W | 1 |
| Chiu, HM | 1 |
| Dotten, DA | 1 |
2 reviews available for dipyridamole and Gangrene
| Article | Year |
|---|---|
[Peripheral arterial occlusions. Principles, possibilities and limits of conservative therapy].
Topics: Ancrod; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Cardiomyopathies; Dextrans; Digitalis | 1981 |
VA cooperative study on antiplatelet agents in diabetic patients after amputation for gangrene. IV. Issues in design, interpretation, and analysis.
Topics: Amputation, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; | 1986 |
3 trials available for dipyridamole and Gangrene
| Article | Year |
|---|---|
V.A. Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: I. Design, methods, and baseline characteristics.
Topics: Amputation, Surgical; Aspirin; Clinical Trials as Topic; Diabetic Angiopathies; Dipyridamole; Epopro | 1984 |
VA cooperative study on antiplatelet agents in diabetic patients after amputation for gangrene. IV. Issues in design, interpretation, and analysis.
Topics: Amputation, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; | 1986 |
V.A. Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: III. Definitions and review of design and baseline characteristics.
Topics: Amputation, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; | 1985 |
5 other studies available for dipyridamole and Gangrene
| Article | Year |
|---|---|
Infantile Kawasaki disease and peripheral gangrene.
Topics: Abciximab; Amputation, Surgical; Anti-Bacterial Agents; Antibodies, Monoclonal; Anticoagulants; Anti | 2006 |
Heritable alpha 2-macroglobulin deficiency in a patient with arterial thrombosis: alpha 2-macroglobulin deficiency Irvine.
Topics: alpha-Macroglobulins; Arteriosclerosis; Aspirin; Dipyridamole; Female; Gangrene; Humans; Immunoelect | 1984 |
Studies on platelet aggregation and antiplatelet therapy in blackfoot disease.
Topics: Adult; Aged; Aspirin; Dipyridamole; Female; Foot Diseases; Gangrene; Humans; Male; Middle Aged; Plat | 1981 |
Gangrene of the toes with palpable peripheral pulses.
Topics: Aged; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Gangrene; Humans; Ischemia; Male; Mi | 1981 |
Fulminant gangrene in transient cold agglutinemia associated with Escherichia coli infection.
Topics: Anemia, Hemolytic, Autoimmune; Cryoglobulins; Cytotoxicity, Immunologic; Dipyridamole; Endocarditis, | 1985 |